Katarina J. Ruscic, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrothorax | 1 | 2023 | 16 | 0.960 |
Why?
|
| Intestinal Perforation | 1 | 2023 | 252 | 0.810 |
Why?
|
| Pleural Effusion | 1 | 2023 | 338 | 0.750 |
Why?
|
| Anesthesia | 2 | 2019 | 1548 | 0.580 |
Why?
|
| Tidal Volume | 1 | 2018 | 489 | 0.550 |
Why?
|
| Lymphatic Vessels | 1 | 2019 | 351 | 0.500 |
Why?
|
| Airway Management | 1 | 2018 | 324 | 0.500 |
Why?
|
| Carbon Dioxide | 1 | 2018 | 1141 | 0.470 |
Why?
|
| Heart Arrest | 1 | 2023 | 1469 | 0.460 |
Why?
|
| Anesthetics | 1 | 2019 | 538 | 0.450 |
Why?
|
| Intermediate-Conductance Calcium-Activated Potassium Channels | 1 | 2013 | 44 | 0.450 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2013 | 104 | 0.440 |
Why?
|
| Anesthesiology | 1 | 2022 | 1043 | 0.420 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2017 | 546 | 0.420 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2013 | 141 | 0.420 |
Why?
|
| Airway Obstruction | 1 | 2017 | 663 | 0.410 |
Why?
|
| Propofol | 1 | 2018 | 628 | 0.410 |
Why?
|
| Wakefulness | 1 | 2018 | 1243 | 0.390 |
Why?
|
| Pancreaticoduodenectomy | 3 | 2019 | 503 | 0.380 |
Why?
|
| Ion Channel Gating | 1 | 2013 | 437 | 0.380 |
Why?
|
| Hypnotics and Sedatives | 1 | 2018 | 1158 | 0.360 |
Why?
|
| Ear, Inner | 1 | 2013 | 420 | 0.330 |
Why?
|
| Lung Diseases | 1 | 2017 | 1884 | 0.290 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 1873 | 0.260 |
Why?
|
| Intraoperative Care | 2 | 2019 | 766 | 0.240 |
Why?
|
| Thoracostomy | 1 | 2023 | 72 | 0.230 |
Why?
|
| Postoperative Complications | 4 | 2019 | 15244 | 0.230 |
Why?
|
| Anesthetics, Inhalation | 2 | 2017 | 571 | 0.200 |
Why?
|
| Pancreatic Fistula | 2 | 2019 | 145 | 0.190 |
Why?
|
| Myocardium | 1 | 2013 | 4775 | 0.180 |
Why?
|
| Lymph | 1 | 2019 | 80 | 0.170 |
Why?
|
| Deep Sedation | 1 | 2018 | 121 | 0.140 |
Why?
|
| Neuromuscular Blockade | 1 | 2018 | 146 | 0.140 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2017 | 130 | 0.140 |
Why?
|
| Postoperative Period | 2 | 2018 | 1839 | 0.130 |
Why?
|
| Perioperative Care | 1 | 2022 | 997 | 0.130 |
Why?
|
| Fluid Therapy | 1 | 2019 | 592 | 0.120 |
Why?
|
| Pulmonary Edema | 1 | 2017 | 415 | 0.120 |
Why?
|
| Respiratory System | 1 | 2017 | 555 | 0.120 |
Why?
|
| Conscious Sedation | 1 | 2018 | 528 | 0.120 |
Why?
|
| Pancreatectomy | 1 | 2018 | 802 | 0.120 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2013 | 31 | 0.110 |
Why?
|
| Electric Conductivity | 1 | 2013 | 411 | 0.100 |
Why?
|
| Sarcopenia | 1 | 2017 | 368 | 0.100 |
Why?
|
| Dexamethasone | 1 | 2018 | 1949 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 2 | 2018 | 5249 | 0.090 |
Why?
|
| Fluorescence | 1 | 2013 | 751 | 0.090 |
Why?
|
| Membrane Potentials | 1 | 2013 | 1135 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 1723 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2013 | 960 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2107 | 0.080 |
Why?
|
| Pneumonia | 2 | 2018 | 2117 | 0.080 |
Why?
|
| Respiratory Insufficiency | 1 | 2017 | 1199 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2017 | 2245 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 6483 | 0.080 |
Why?
|
| Oocytes | 1 | 2013 | 1186 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 1631 | 0.080 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2017 | 1808 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2017 | 3679 | 0.060 |
Why?
|
| Length of Stay | 1 | 2017 | 6294 | 0.060 |
Why?
|
| Humans | 10 | 2023 | 742088 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7276 | 0.040 |
Why?
|
| Incidence | 1 | 2017 | 20928 | 0.040 |
Why?
|
| Male | 6 | 2023 | 349538 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2018 | 520 | 0.040 |
Why?
|
| Abdominal Abscess | 1 | 2018 | 154 | 0.040 |
Why?
|
| Adult | 2 | 2023 | 213712 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2017 | 23320 | 0.030 |
Why?
|
| Neuromuscular Diseases | 1 | 2018 | 253 | 0.030 |
Why?
|
| Sepsis | 2 | 2019 | 2589 | 0.030 |
Why?
|
| Survival Rate | 2 | 2018 | 12773 | 0.030 |
Why?
|
| Hospital Mortality | 2 | 2019 | 5310 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2018 | 786 | 0.030 |
Why?
|
| Young Adult | 1 | 2018 | 56350 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2017 | 980 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 72145 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 3471 | 0.020 |
Why?
|
| Propensity Score | 1 | 2017 | 1771 | 0.020 |
Why?
|
| Female | 5 | 2019 | 379592 | 0.020 |
Why?
|
| Research | 1 | 2018 | 1999 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 1538 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 2017 | 1357 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6534 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10248 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.020 |
Why?
|
| Middle Aged | 4 | 2019 | 213127 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12344 | 0.010 |
Why?
|
| Massachusetts | 1 | 2017 | 8662 | 0.010 |
Why?
|
| Aged | 3 | 2019 | 162944 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2018 | 77098 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29010 | 0.010 |
Why?
|
| Time Factors | 1 | 2018 | 40054 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 40450 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 57683 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2017 | 53187 | 0.010 |
Why?
|